Harpreet Grewal, MD
Clinical Cardiac Electrophysiology · Mechanicsville, VANPI 1093826083
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 61.4% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $20,209 and has fallen 50.9% since, to $9,929 in 2025.
Across 273 payments — averaging $221.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$37K
- Johnson & Johnson$12K
- Medtronic$4K
- Atricure, Inc.$2K
- Biosense Webster, Inc.$1K
- Philips North America LLC$1K
- plus $3K from 20 others
Across 54 payments — averaging $1897.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$69K
- Impulse Dynamics (USA) Inc.$20K
- Medtronic$13K
What the payments were for
- Consulting fees$22,05036%
- Speaking & faculty fees$24,35040%
- Travel & lodging$5,6419%
- Food & beverage$8,48514%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 108 | $37,188 |
| Johnson & Johnson | 17 | $12,012 |
| Medtronic(2 entities) | 36 | $3,823 |
| Atricure, Inc. | 7 | $1,683 |
| Biosense Webster, Inc. | 9 | $1,336 |
| Philips North America LLC | 13 | $1,243 |
| Medical Device Business Services, Inc. | 5 | $1,077 |
| Abbott | 10 | $687 |
| Impulse Dynamics (USA) Inc. | 8 | $473 |
| Pfizer | 11 | $186 |
| Novartis | 11 | $177 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $161 |
| Amgen | 7 | $114 |
| Cardiva Medical, Inc. | 3 | $65 |
| Covidien LP | 1 | $63 |
| E.r. Squibb & Sons, L.L.C. | 4 | $50 |
| Siemens Medical Solutions USA, Inc. | 1 | $27 |
| Heartflow, Inc. | 1 | $25 |
| Angiodynamics, Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Biotronik Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$19,754
- XARELTO$11,646
- Micra$2,554
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,611
- (9124) LM Undivided$1,079
- Carto 3 System$1,077
- Carto 3$886
- OPTIMIZER$431
- Watchman$386
- WATCHMAN Access System$238
- MitraClip$237
- Farapulse$148
- INGEVITY$146
- LINQ II$145
- Ensite Cardiac Mapping System$140
- COBALT DR MRI SURESCAN$126
- COREVALVE EVOLUT R$125
- Advisa$124
- Carto Smarttouch$123
- Amplia MRI$116
How this compares
$60,531 in reported general payments places this provider in the 80th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 50 | $53,074 |
| XareltoRivaroxaban | 30 | $27,756 |
| ClopidogrelClopidogrel Bisulfate | 87 | $1,031 |
| Amiodarone Hcl | 52 | $533 |
| Metoprolol Succinate | 37 | $239 |
| Carvedilol | 12 | $149 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $186 | $53,07450 claims |
| Johnson & JohnsonXarelto | $12,012 | $27,75630 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Mechanicsville
- Kenneth EllenbogenRichmond$360K
- Brett AtwaterFairfax$319K
- Oliver MonfrediCharlottesville$231K
- Peem LorvidhayaFredericksburg$230K
- Erich KiehlNewport News$181K
- Emmanuel EkanemWinchester$132K
- Pamela MasonCharlottesville$130K
- Ajay PillaiRichmond$129K
- Stephen GaetaFairfax$85K
- Charles JoynerRichmond$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.